糖尿病

订阅

MedSci主页 / 所有栏目 / 糖尿病

Diabetologia：胰岛素分泌和清除的作用？

2018-04-12 MedSci MedSci原创

胰岛素分泌清除
关注

近日，国际杂志 《Diabetologia》上在线发表一项关于适应肥胖的胰岛素抵抗-胰岛素分泌和清除的作用的研究。这项研究的目的是量化在无糖尿病的胰岛素抵抗个体的代偿性高胰岛素血症特征中增加的胰岛素分泌率（ISR）和降低的胰岛素清除率（ICR）的相对贡献。 研究人员从志愿者登记处确定肥胖（BMI≥30 kg/m 2）的无糖尿病个体（n = 91）。并对志愿者进行了以下测量：口服葡萄糖耐量；胰

近日，国际杂志 《Diabetologia》上在线发表一项关于适应肥胖的胰岛素抵抗-胰岛素分泌和清除的作用的研究。这项研究的目的是量化在无糖尿病的胰岛素抵抗个体的代偿性高胰岛素血症特征中增加的胰岛素分泌率（ISR）和降低的胰岛素清除率（ICR）的相对贡献。 研究人员从志愿者登记处确定肥胖（BMI≥30 kg/m 2）的无糖尿病个体（n = 91）。并对志愿者进行了以下测量：口服葡萄糖耐量；胰岛素抵抗（胰岛素抑制试验[IST]期间的稳态血浆葡萄糖[SSPG]浓度）;ISR（使用分级葡萄糖输注试验[GGIT]）和ICR（使用IST和GGIT）。根据SSPG浓度分为三等：SSPG-1（对胰岛素敏感）； SSPG-2（中级）和SSPG-3（胰岛素抵抗）。 研究发现SSPG三分位数在BMI和腰围方面没有差异。与SSPG-1组相比，SSPG-2和SSPG-3组的血清丙氨酸转氨酶浓度更高（p=0.02）。在口服葡萄糖激发后，从胰岛素敏感性最高的到胰岛素抵抗最强的三分位组胰岛素总应答量逐渐增加（p<0.001）。在静脉输注葡萄糖后，与SSPG-1组（30.3 [28.8-32.9] mmol /

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1760637, encodeId=07681e60637d3, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Apr 12 21:12:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682424, encodeId=c41d168242467, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Nov 18 02:12:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638554, encodeId=7e9c163855449, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jul 18 17:12:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749954, encodeId=632c1e49954ec, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Jan 25 03:12:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393491, encodeId=e39913934913b, content=<a href='/topic/show?id=6162838e390' target=_blank style='color:#2F92EE;'>#胰岛素分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83873, encryptionId=6162838e390, topicName=胰岛素分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Apr 14 06:12:00 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-04-12 ms5439512287675881

    #BET#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1760637, encodeId=07681e60637d3, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Apr 12 21:12:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682424, encodeId=c41d168242467, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Nov 18 02:12:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638554, encodeId=7e9c163855449, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jul 18 17:12:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749954, encodeId=632c1e49954ec, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Jan 25 03:12:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393491, encodeId=e39913934913b, content=<a href='/topic/show?id=6162838e390' target=_blank style='color:#2F92EE;'>#胰岛素分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83873, encryptionId=6162838e390, topicName=胰岛素分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Apr 14 06:12:00 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-11-18 gwc392

    #分泌#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1760637, encodeId=07681e60637d3, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Apr 12 21:12:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682424, encodeId=c41d168242467, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Nov 18 02:12:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638554, encodeId=7e9c163855449, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jul 18 17:12:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749954, encodeId=632c1e49954ec, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Jan 25 03:12:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393491, encodeId=e39913934913b, content=<a href='/topic/show?id=6162838e390' target=_blank style='color:#2F92EE;'>#胰岛素分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83873, encryptionId=6162838e390, topicName=胰岛素分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Apr 14 06:12:00 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-07-18 ms9608593228839890

    #DIA#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1760637, encodeId=07681e60637d3, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Apr 12 21:12:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682424, encodeId=c41d168242467, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Nov 18 02:12:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638554, encodeId=7e9c163855449, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jul 18 17:12:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749954, encodeId=632c1e49954ec, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Jan 25 03:12:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393491, encodeId=e39913934913b, content=<a href='/topic/show?id=6162838e390' target=_blank style='color:#2F92EE;'>#胰岛素分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83873, encryptionId=6162838e390, topicName=胰岛素分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Apr 14 06:12:00 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2019-01-25 仁医06

    #胰岛#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1760637, encodeId=07681e60637d3, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Apr 12 21:12:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682424, encodeId=c41d168242467, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Sun Nov 18 02:12:00 CST 2018, time=2018-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638554, encodeId=7e9c163855449, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jul 18 17:12:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749954, encodeId=632c1e49954ec, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Jan 25 03:12:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393491, encodeId=e39913934913b, content=<a href='/topic/show?id=6162838e390' target=_blank style='color:#2F92EE;'>#胰岛素分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83873, encryptionId=6162838e390, topicName=胰岛素分泌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Apr 14 06:12:00 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-04-14 jingyanzhu715_39486101

    #胰岛素分泌#

    0

相关资讯

Diabetes：人类和体外证据证明：持久性有机物质污染会损坏胰腺β细胞的胰岛素分泌功能

持久性有机污染物质（POPs），特别是有机氯农药（OCPs）以及多氯联苯（PCBs）已然成为诱发2型糖尿病（T2D）的新的风险因子。我们于人体及体外探究了慢性低剂量暴露于持久性有机污染物中的时候，胰腺β细胞的胰岛素分泌时候会受到影响。在200位非糖尿病成年人中测定有机氯农药和多氯联苯的免疫血清浓度。基于精确数学模型的胰岛素分泌指标通过一个2小时7样本口服葡萄糖耐量实验获得。INS1E β细胞的胰岛

Diabetes Care：艾塞那肽对大脑活动和胰岛素分泌有啥影响？

艾塞那肽(Exenatide)是第一个肠降血糖素类似物，是人工合成的由39个氨基酸组成的多肽，与内源性肠降血糖素如胰高血糖素样肽-1(GLP-1)作用相似，具有促进葡萄糖依赖的胰岛素分泌，恢复第一时相胰岛素分泌，抑制胰高血糖素的分泌，减慢胃内容物的排空，改善胰腺β细胞的功能等作用。 目的：本研究对象为消瘦和肥胖的糖耐量正常个体，旨在调查艾塞那肽对大脑活动（通过功能磁共振成像(f)MRI测量）

Metabolism：循环甘油三酯而不是胰腺脂肪与健康人胰岛素分泌有关！

由此可见，非糖尿病患者血脂及血清脂联素与β细胞功能之间的相关性可能是适应胰岛素敏感性下降的一种代偿反应。

Diabetes：利用靶向RNAi筛查探寻调控胰腺β细胞GLP-1R的内吞转运因子——治疗T2D的新的药物靶点。

GLP-1受体（GLP-1R）是治疗2型糖尿病（T2D）的重要靶点。鉴于激动剂结合受体的内吞转移是调控受体信号的重要途径之一，良好的了解这一过程可能会促进研发新的治疗T2D的方案。研究人员筛选出29种已知的在G蛋白偶联受体转运过程中具有一定的功能的蛋白质——在GLP-1R增强胰腺β细胞分泌胰岛素的过程中或可发挥一定作用。研究人员通过用GLR-1类似物exendin-4处理小鼠胰腺瘤MIN6B1细胞

Diabetes Care：维生素D补充对2型糖尿病伴维生素D缺乏患者胰岛素敏感性和胰岛素分泌的影响！

由此可见，T2D伴有低维生素D的患者补充大剂量的维生素D3没有改变胰岛素敏感性和胰岛素分泌。这些研究结果并不支持采用维生素D3的补充治疗来改善T2D患者的血糖稳态。

Diabetes Obes Metab：非马沙坦可增加高血压合并2型糖尿病患者葡萄糖刺激的胰岛素分泌！

由此可见，与氨氯地平相比，非马沙坦可增加2型糖尿病和高血压患者的晚期葡萄糖刺激的胰岛素分泌。这一发现表明，与其他类型的抗高血压药相比，ARB对这些患者更有利。